Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. - Wikidata - wikimedia - TriplyDB

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

http://www.wikidata.org/entity/Q33674118

about

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.Detection of a variant protein in hair: new diagnostic method in Portuguese type familial amyloid polyneuropathy.Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.Transthyretin mutations in hyperthyroxinemia and amyloid diseases.Guideline of transthyretin-related hereditary amyloidosis for clinicians.TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?Recent progress in the understanding and treatment of transthyretin amyloidosis.Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.Fibrinogen A alpha chain Leu 554: an African-American kindred with late onset renal amyloidosis.A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.Diagnosis of familial amyloid polyneuropathy: wide-ranged clinicopathological features.Waiting for a liver transplant: the experience of patients with familial amyloidotic polyneuropathy.Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life.The neuroendocrine system and gastrointestinal complications in patients with familial amyloidosis and polyneuropathy.Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy.Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy.Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation.Successful pregnancies and fatherhood in familial amyloidotic polyneuropathy (FAP Val30Met) patients with liver transplantation.Amyloid polyneuropathy caused by wild-type transthyretin.Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study.Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus.Frequency of the transthyretin Val30Met mutation in the northern Swedish population Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis Difficulties in clinical diagnosis and prediction of outcome in patients with the transthyretin Met 30 mutation: Report of two cases Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR VaBOMet)Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val3 et) - comparison of Swedish and Japanese patients

P2860

Q26782089-612166DE-8423-4799-AAA2-090CBA714687 Q28078350-1DBF260C-6AE6-49A6-A47B-9C694CA00BED Q33692348-93227EF0-DDAD-4A85-9FFD-67328E825C65 Q33791776-4A5F7741-ADEE-4758-9AC3-80D773A66DAC Q33949040-2BFE12AA-012D-4945-BAAE-12FDA8A3819F Q34073701-278DA6A3-8009-4EE4-823E-9A0F3158A5E1 Q34269382-0010DD7E-7631-4302-BE15-02EE2A0BF5D4 Q34328734-0E653F43-B39E-4A2D-B10C-8201D6A3F5A4 Q34329412-10081E5F-0D8D-4D99-8F9A-B5298AFE6B13 Q34416193-5A79126D-20D9-4F8A-A599-3117D2ACCB8D Q34443897-1A78944B-0E30-4461-BFC3-5F078944F26C Q34480186-4CF721C2-3424-4535-A58D-23AF17068D98 Q35456927-A5B107DA-C187-4882-95F6-8E3CB1400B6A Q35850786-A3930130-20D9-4A69-9BDB-66616B6A1B11 Q36151383-7921166E-D1D5-4AD4-8243-49CB4AE0216C Q37202287-4BAF5F07-BB59-4E0F-80BB-74497AE4B06D Q37335475-03376758-67BA-4768-8642-B818C56B45E3 Q37778217-9FFDA5BC-EECF-462F-A481-7EC587821FEA Q37893109-C41F7EC3-FD2D-4F8A-8235-18FC1A130233 Q38089871-A70A137C-953D-464F-B7EC-DC4C3175681F Q39425999-85ECD040-59A9-4C8F-A0AF-89C2BA953F52 Q40714600-82291A98-DCF6-411D-990B-986A65043611 Q41595462-9FEA762D-7EB5-4C27-BA47-4D036EA66BA1 Q43471530-63D9E478-981A-4154-878D-FE8ECF78B9E3 Q43924602-9AC67151-17A0-443A-AB82-78082FAB906D Q44155172-50E9E79F-6F80-4E16-98E9-306F6FBF9366 Q45102168-CA16B379-9498-4E66-A7E8-B94839EFBA87 Q46104326-B59DEE09-22C4-48C0-8E90-725B26633B4B Q47561760-21ACD112-AD41-460C-9222-A84D957B7F6B Q47593376-0D5B16AE-4F94-413B-ABE5-16C9B656DF02 Q48101196-45152094-57D5-42C3-B52E-3470B6FED66B Q50856561-5F629E06-4143-43A7-9E2B-04B97DAD7E0A Q51765699-E53BCDBD-D523-43BE-BAE0-9E6DC12380BC Q57259323-032ECA73-E63A-4F30-8626-D3F2E4D4ACE0 Q57259363-9E12310F-D33E-4689-9BC6-49D119E76ADD Q57259431-93BC7275-4838-4D7A-A5DE-EF41F1230199 Q57259480-B2B411D1-AC70-41B5-AA8C-66B080B2316F Q57259497-4D1CE4C0-4077-490A-88B5-96BCE0991AB5 Q57587982-BA933880-70AF-4E98-B620-D874A55F350D Q58125049-1FDBDEFA-2D46-4307-A668-EE5920C48BE7

P2860

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

http://www.wikidata.org/entity/Q33674118

description

1994 nî lūn-bûn

@nan

1994 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Geographical distribution of T ...... frequency and prevalence rate.

@ast

Geographical distribution of T ...... frequency and prevalence rate.

@en

type

label

Geographical distribution of T ...... frequency and prevalence rate.

@ast

Geographical distribution of T ...... frequency and prevalence rate.

@en

prefLabel

Geographical distribution of T ...... frequency and prevalence rate.

@ast

Geographical distribution of T ...... frequency and prevalence rate.

@en

P1433

Q33674118-B4BA2C08-182B-4F84-A717-DA7230561204

P1476

Q33674118-1485AEB3-5FDD-41B8-887D-28182F4D3DBD

P2093

Q33674118-213A5227-F563-4C77-890F-C47234F38523

Q33674118-22FAD558-D24A-473B-9E46-5521B9B70D02

Q33674118-2D5A9EF3-7AE2-4D77-A166-DAB4E0B0AC1D

Q33674118-39D9F40F-976C-4E38-B939-644BCBD261A2

Q33674118-6B8620B6-F464-4C45-9C91-FC521484EE0D

Q33674118-8C94A03F-8708-44AE-BEFF-726A6D78CF0D

Q33674118-9C33639A-0E01-4FE7-87F4-12DAA91DB770

Q33674118-A38ADCE0-45FE-4FC9-9D14-97300F6B26A5

Q33674118-AC09A2D8-E495-4FD8-88B1-2C7A66FA9349

Q33674118-DE745DF4-1081-4C26-AEC2-73AA5325BDED

P2860

Q33674118-03715196-D491-4EA2-9DFC-DBD97E67C82E

Q33674118-47DD1E77-DCF5-4EE5-8DAD-2E9E5FD08F25

Q33674118-91359469-BB39-48EC-B216-468AA746A201

Q33674118-C04DBB51-5346-472C-A1F5-7D03FC2A61DF

Q33674118-C6F31536-0E28-4833-91A4-DB0556C423BF

Q33674118-CF9274DD-5F36-43EF-807E-FAB00628529D

Q33674118-F80686F3-2B8E-4F3C-86A3-A7836B6341F0

P304

Q33674118-888A3AEE-A929-4370-B347-F286247D1D7F

P31

Q33674118-D8E28141-5B93-4076-90E6-C7B8F2CA02B0

P356

Q33674118-6C9A5741-234B-43F1-A4E8-10A461B61F3D

P407

Q33674118-E7983CE1-76D7-4553-B007-852B62443237

P433

Q33674118-4C95CC7B-D927-4B52-967B-DE3660DA6E79

P478

Q33674118-B59D807E-BCEB-4AD2-8974-291E696E1FFE

P577

Q33674118-1C1F1157-E69F-4C84-BB06-ACB858B33D66

P5875

Q33674118-6C6C90EB-F57F-43AA-9EA7-4DD4344896C8

P698

Q33674118-8C4A15C6-86CC-4038-95B4-B56C5C701253

P921

Q33674118-71EA6E74-3483-4DA9-BB2A-3BD5A6912520

P932

Q33674118-1B0A065D-06ED-410A-B72A-7DAAF4F29A86

P356

P1433

Journal of Medical Genetics

P1476

Geographical distribution of T ...... frequency and prevalence rate.

@en

P2093

Andersson C

http://www.w3.org/2001/XMLSchema#string

Asplund K

http://www.w3.org/2001/XMLSchema#string

Beckman L

http://www.w3.org/2001/XMLSchema#string

Costa PM

http://www.w3.org/2001/XMLSchema#string

Costa PP

http://www.w3.org/2001/XMLSchema#string

Holmgren G

http://www.w3.org/2001/XMLSchema#string

Nylander PO

http://www.w3.org/2001/XMLSchema#string

Saraiva MJ

http://www.w3.org/2001/XMLSchema#string

Steen L

http://www.w3.org/2001/XMLSchema#string

Teixeira A

http://www.w3.org/2001/XMLSchema#string

P2860

Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy

Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence.

Population studies in northern Sweden. XVII. Estimates of Finnish and Saamish influence.

Linkage of G8 (D4S10) in two Swedish families with Huntington's disease.

Diagnosis of familial amyloidotic polyneuropathy by recombinant DNA techniques.

Polymorphism of human plasma thyroxine binding prealbumin.

P304

351-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JMG.31.5.351

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

1994-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15134057

http://www.w3.org/2001/XMLSchema#string

P698

8064809

http://www.w3.org/2001/XMLSchema#string

P921

P932

1049863

http://www.w3.org/2001/XMLSchema#string